ZA922073B - New compounds for use in the treatment of cancer - Google Patents
New compounds for use in the treatment of cancerInfo
- Publication number
- ZA922073B ZA922073B ZA922073A ZA922073A ZA922073B ZA 922073 B ZA922073 B ZA 922073B ZA 922073 A ZA922073 A ZA 922073A ZA 922073 A ZA922073 A ZA 922073A ZA 922073 B ZA922073 B ZA 922073B
- Authority
- ZA
- South Africa
- Prior art keywords
- cancer
- treatment
- new compounds
- compounds
- new
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919106170A GB9106170D0 (en) | 1991-03-22 | 1991-03-22 | New compounds for use in the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA922073B true ZA922073B (en) | 1992-11-25 |
Family
ID=10692068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA922073A ZA922073B (en) | 1991-03-22 | 1992-03-20 | New compounds for use in the treatment of cancer |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0505220A1 (enExample) |
| JP (1) | JPH06511229A (enExample) |
| AU (1) | AU1566792A (enExample) |
| CA (1) | CA2106868A1 (enExample) |
| GB (1) | GB9106170D0 (enExample) |
| IE (1) | IE920889A1 (enExample) |
| IL (1) | IL101317A0 (enExample) |
| MX (1) | MX9201258A (enExample) |
| TW (1) | TW202437B (enExample) |
| WO (1) | WO1992016513A1 (enExample) |
| ZA (1) | ZA922073B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| GB9219776D0 (en) * | 1992-09-18 | 1992-10-28 | Inst Of Cancer The Research | New compounds for use in the treatment of cancer |
| JP2002509140A (ja) * | 1998-01-13 | 2002-03-26 | アナディーズ・ファーマスーティカルズ，インコーポレイテッド | トリアジン抗ウイルス化合物 |
| US6335339B1 (en) | 1998-01-13 | 2002-01-01 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| WO2009157628A1 (en) * | 2008-06-23 | 2009-12-30 | Industry-Academic Cooperation Foundation, Yonsei University | Pharmaceutical composition for treating or preventing cancer comprising triazine compound as an active ingredient |
| CN101684115B (zh) * | 2008-09-26 | 2011-12-21 | 上海医药工业研究院 | 4-(5-((2-(4-吗啉基-6-苯氨基-1,3,5-三嗪-2-基)亚肼基)甲基)呋喃-2-基)苯甲酸、其制备方法及用途 |
| BR112015011213A2 (pt) * | 2012-11-15 | 2017-08-29 | Galleon Pharmaceuticals Inc | Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição. |
-
1991
- 1991-03-22 GB GB919106170A patent/GB9106170D0/en active Pending
-
1992
- 1992-03-20 ZA ZA922073A patent/ZA922073B/xx unknown
- 1992-03-20 IE IE088992A patent/IE920889A1/en unknown
- 1992-03-20 MX MX9201258A patent/MX9201258A/es unknown
- 1992-03-20 IL IL101317A patent/IL101317A0/xx unknown
- 1992-03-21 TW TW081102138A patent/TW202437B/zh active
- 1992-03-23 CA CA002106868A patent/CA2106868A1/en not_active Abandoned
- 1992-03-23 WO PCT/GB1992/000525 patent/WO1992016513A1/en not_active Ceased
- 1992-03-23 JP JP4506407A patent/JPH06511229A/ja active Pending
- 1992-03-23 EP EP92302491A patent/EP0505220A1/en not_active Ceased
- 1992-03-23 AU AU15667/92A patent/AU1566792A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2106868A1 (en) | 1992-09-23 |
| IE920889A1 (en) | 1992-09-23 |
| GB9106170D0 (en) | 1991-05-08 |
| TW202437B (enExample) | 1993-03-21 |
| EP0505220A1 (en) | 1992-09-23 |
| MX9201258A (es) | 1992-10-01 |
| JPH06511229A (ja) | 1994-12-15 |
| IL101317A0 (en) | 1992-11-15 |
| WO1992016513A1 (en) | 1992-10-01 |
| AU1566792A (en) | 1992-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA957483B (en) | Compounds and methods for the treatment of cancer | |
| ZA928832B (en) | Local delivery of dipyridamole for the treatment of proliferative diseases | |
| HU9302636D0 (en) | Compounds against cancer | |
| GB9305470D0 (en) | New substituted azetidinones useful in the treatment of cancer | |
| EP0499467A3 (en) | Use of quinones in the treatment of cancer or aids | |
| IL101410A0 (en) | Formulation for the treatment of cancer | |
| GB9303210D0 (en) | Cancer treatment | |
| GB9106170D0 (en) | New compounds for use in the treatment of cancer | |
| ZA928198B (en) | Substituted azaspiranes for use in the treatment of hyperlipidemia | |
| GB9219776D0 (en) | New compounds for use in the treatment of cancer | |
| GB9218711D0 (en) | Skin cancer treatment | |
| GB9100970D0 (en) | Acne treatment composition | |
| GB9117819D0 (en) | Therapeutic compounds | |
| EP0460690A3 (en) | Use of phenolsulfophthaline derivatives for the treatment of osteoporosis | |
| GB9214239D0 (en) | Compounds useful for treating tumours | |
| ZA899631B (en) | Cancer treatment | |
| GB9014132D0 (en) | Agent for therapy | |
| GB9026737D0 (en) | Cancer treatment | |
| GB2255725B (en) | Liquid treatment | |
| GB9119081D0 (en) | Cancer therapy and compositions for use therein | |
| GB9117210D0 (en) | Treatment of cancer | |
| GB9104175D0 (en) | New treatment | |
| GB9008524D0 (en) | Treatment of cancer | |
| GB9112552D0 (en) | Method and composition for the treatment of cancer | |
| GB9123572D0 (en) | Pharmaceutical compositions and methods for the treatment of malignancy |